Pierre Gagnon
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Profil
Mr. Pierre Gagnon is a Chief Operating Officer at NKGen Biotech, Inc. He is on the Board of Directors at ATGen Canada, Inc. Mr. Gagnon was previously employed as a Chief Operating Officer by NKGen Biotech, Inc. /US/ and a Director-Global Operations & Director by NKMAX Co., Ltd.
He received his undergraduate degree from the University of Quebec.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 29.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Pierre Gagnon
| Unternehmen | Position | Beginn |
|---|---|---|
| ATGen Canada, Inc. | Direktor/Vorstandsmitglied | 01.05.2013 |
Ehemalige bekannte Positionen von Pierre Gagnon
| Unternehmen | Position | Ende |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Geschäftsführer | 01.09.2023 |
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Geschäftsführer | 01.06.2019 |
Ausbildung von Pierre Gagnon
| University of Quebec | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| ATGen Canada, Inc. | |
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
